Learn about the stages of prostate cancer and what they mean. Trust the compassionate oncology team at Regional Cancer Care Associates.| Regional Cancer Care Associates
A drug called Lu177-PSMA-617 may be a new option for treating advanced prostate cancer. In a large clinical trial called VISION, participants who received 177Lu-PSMA-617—a type of drug called a radiopharmaceutical—along with standard treatments lived longer than those who received only standard therapies.| www.cancer.gov
RCCA is the leading provider of advanced cancer care and treatment in NJ, MD and CT. Call us at 201-669-4706 so that we can help you and your loved ones navigate the overwhelming journey past a cancer diagnosis.| Regional Cancer Care Associates
Regional Cancer Care Associates has more than 25 locations throughout New Jersey, Connecticut, Maryland, and surrounding areas. Find your location online.| Regional Cancer Care Associates
Monoclonal antibodies and small-molecule drugs are forms of targeted therapy. Explore treatment options with Regional Cancer Care Associates.| Regional Cancer Care Associates
Our cancer specialists take a patient-centric, innovative approach to treating all types of cancers. Learn how to schedule a consultation in MD, CT, or NJ at Regional Cancer Care Associates.| Regional Cancer Care Associates
Learn about clinical trials and how the professionals at Regional Cancer Care Associates assure the highest quality of care. Call 201-518-3587 today.| Regional Cancer Care Associates